Clinical trials for prostate cancer
62 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 1 / Phase 2
Prostate cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M8
Metastatic Hormone-sensitive
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 2 more...)
Constellation Pharmaceutique
Phase 1 / Phase 2
Prostate cancer
#NCT06353386
Adenocarcinoma
Metastatic Castration-resistant
1
2
3 or more
Hormone therapy
Hormone therapy
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Institut Bergonié (Bordeaux)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2
Prostate cancer
#NCT04585750
Metastatic Castration-resistant
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nîmes (Nîmes), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 4 more...)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Prostate cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M6
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 2 more...)
Constellation Pharmaceutique
Phase 1 / Phase 2
Breast cancer
Prostate cancer
#NCT05592626
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Metastatic Castration-resistant
MSI/dMMR
1
2
3 or more
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Centre Léon Bérard (Lyon), IUCT Oncopôle (Toulouse), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux)
Marengo Therapeutics, Inc.
Phase 1 / Phase 2
#NCT04262466
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Institut Curie - Paris (Paris)
Immunocore Ltée
Phase 1
Centre Antoine Lacassagne (Nice)
Phase 1
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Phase 1
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Phase 1
Hôpital Saint Louis AP-HP (Paris)